- What is Crossroad Venture Capital Fund's primary investment focus?
- Crossroad Venture Capital Fund primarily invests in early-stage Israeli companies with innovative intellectual property, strong management teams, and high market potential. They focus on sectors such as medical devices, information and communication technology, renewable energy, biotechnology, and pharmaceuticals.
- Which investment stages does Crossroad Venture Capital Fund target?
- Crossroad Venture Capital Fund targets Seed and Pre-Seed stage investments.
- Can you name a notable exit for Crossroad Venture Capital Fund?
- Crossroad Venture Capital Fund had an exit with Roboteam, which was acquired by Ondas Holdings for $80M in November 2025.
- What is another significant exit for Crossroad Venture Capital Fund?
- Another significant exit for Crossroad Venture Capital Fund is Regentis Biomaterials, which had a PO Event in September 2025, raising $11M and listing on NASDAQ.
- Who are the key team members at Crossroad Venture Capital Fund?
- The key team members at Crossroad Venture Capital Fund include Itamar Borowitz, a Managing Partner, and Itay Attar and Dudu Peri, both Investment Managers.
- What is Crossroad Venture Capital Fund's geographic focus for investments?
- Crossroad Venture Capital Fund focuses mainly on Israeli companies, with its HQ in Tel Aviv-Yafo, Israel.
- What is the most common sector for Crossroad Venture Capital Fund's portfolio companies?
- The most common sector for Crossroad Venture Capital Fund's portfolio companies is Health Tech & Life Sciences, accounting for 5 out of 7 companies.
- What is Crossroad Venture Capital Fund's investment range?
- Crossroad Venture Capital Fund's investment range is between $1.7M and $30M.
